Hofseth Biocare ASA Capital Reinvestment Ratio
Hofseth Biocare ASA capital reinvestment ratio. Hofseth Biocare ASA (HBC) has a Capital Reinvestment Ratio of 1.43x as of December 2024, meaning it reinvests 1% of its operating cash flow (Nkr851.00K) in capital expenditures (Nkr1.22 Million). See Hofseth Biocare ASA free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Hofseth Biocare ASA (2015–2023)
Capital reinvestment ratio of Hofseth Biocare ASA from 2015 to 2023. This chart tracks Hofseth Biocare ASA's Capital Reinvestment Ratio across 2 annual periods. See financial flexibility index of Hofseth Biocare ASA to measure the company's free cash flow as a share of total liabilities.
Hofseth Biocare ASA Capital Reinvestment Ratio by Year (2015–2023)
Hofseth Biocare ASA capital reinvestment ratio by year from 2015 to 2023. For the full cash flow conversion analysis, see Hofseth Biocare ASA operating cash flow efficiency.
| Year | Reinvestment Ratio | Operating CF (NOK) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 2.97x | Nkr2.76 Million | Nkr8.19 Million | ▲ +99.7% |
| 2015 | 1.49x | Nkr7.97 Million | Nkr11.84 Million | — |